Skip to main content
SpringerLink
Log in

Defining vascular signatures of benign hepatic masses: role of MDCT with 3D rendering

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Multidetector CT (MDCT) provides new opportunities for hepatic tumor characterization. By coupling high-resolution isotropic datasets with advanced post-processing tools, maps of tumor vascularity can be generated to elucidate characteristic findings. This two-part review describes a range of benign and malignant liver masses, with emphasis on IV contrast-enhanced MDCT features and vascular signatures that can be identified on 3D vascular mapping.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Foley WD, Mallisee TA, Hohenwalter MD, et al. (2000) Multiphase hepatic CT with a multirow detector CT scanner. AJR Am J Roentgenol 175:679–685

    Article  PubMed  CAS  Google Scholar 

  2. Francis IR, Cohan RH, McNulty NJ, et al. (2003) Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol 180:1217–1224

    Article  PubMed  Google Scholar 

  3. Johnson PT, Fishman EK (2006) IV contrast selection for MDCT: current thoughts and practice. AJR Am J Roentgenol 186:406–415

    Article  PubMed  Google Scholar 

  4. Yanaga Y, Awai K, Nakaura T, et al. (2008) Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT. AJR Am J Roentgenol 190:1003–1009

    Article  PubMed  Google Scholar 

  5. Bae KT (2010) Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Radiology 256:32–61

    Article  PubMed  Google Scholar 

  6. Heiken JP, Brink JA, McClennan BL, et al. (1995) Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology 195:353–357

    PubMed  CAS  Google Scholar 

  7. Cowles RA, Mulholland MW (2000) Solitary hepatic cysts. J Am Coll Surg 191:311–321

    Article  PubMed  CAS  Google Scholar 

  8. Carrim ZI, Murchison JT (2003) The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 58:626–629

    Article  PubMed  CAS  Google Scholar 

  9. Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369:1287–1301

    Article  PubMed  Google Scholar 

  10. Inaba T, Nagashima I, Ogawa F, et al. (2003) Diffuse intrahepatic bile duct dilation caused by a very small hepatic cyst. J Hepatobiliary Pancreat Surg 10:106–108

    PubMed  Google Scholar 

  11. Mortele KJ, Segatto E, Ros PR (2004) The infected liver: radiologic–pathologic correlation. Radiographics 24:937–955

    Article  PubMed  Google Scholar 

  12. Halvorsen RA, Korobkin M, Foster WL, et al. (1984) The variable CT appearance of hepatic abscesses. AJR Am J Roentgenol 142:941–946

    Article  PubMed  CAS  Google Scholar 

  13. Zonios D, Soula M, Archimandritis AJ, et al. (2003) Cystlike hepatic metastases from gastrointestinal stromal tumors could be seen before any treatment. AJR Am J Roentgenol 181:282 (author reply 282)

    Article  PubMed  Google Scholar 

  14. Freeny PC (1983) Angiography of hepatic neoplasms. Semin Roentgenol 18:114–122

    Article  PubMed  CAS  Google Scholar 

  15. Karhunen PJ (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39:183–188

    Article  PubMed  CAS  Google Scholar 

  16. Gandolfi L, Leo P, Solmi L, et al. (1991) Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut 32:677–680

    Article  PubMed  CAS  Google Scholar 

  17. Farges O, Daradkeh S, Bismuth H (1995) Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg 19:19–24

    Article  PubMed  CAS  Google Scholar 

  18. Saegusa T, Ito K, Oba N, et al. (1995) Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med 34:207–211

    Article  PubMed  CAS  Google Scholar 

  19. Biecker E, Fischer HP, Strunk H, et al. (2003) Benign hepatic tumours. Z Gastroenterol 41:191–200

    Article  PubMed  CAS  Google Scholar 

  20. Kamel IR, Liapi E, Fishman EK (2005) Liver and biliary system: evaluation by multidetector CT. Radiol Clin North Am 43:977–997, vii

    Google Scholar 

  21. Oto A, Tamm EP, Szklaruk J (2005) Multidetector row CT of the liver. Radiol Clin North Am 43:827–848, vii

    Google Scholar 

  22. Belli L, De Carlis L, Beati C, et al. (1992) Surgical treatment of symptomatic giant hemangiomas of the liver. Surg Gynecol Obstet 174:474–478

    PubMed  CAS  Google Scholar 

  23. Ungermann L, Elias P, Zizka J, et al. (2007) Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol 63:290–294

    Article  PubMed  Google Scholar 

  24. Buetow PC, Pantongrag-Brown L, Buck JL, et al. (1996) Focal nodular hyperplasia of the liver: radiologic–pathologic correlation. Radiographics 16:369–388

    PubMed  CAS  Google Scholar 

  25. Wanless IR, Mawdsley C, Adams R (1985) On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5:1194–1200

    Article  PubMed  CAS  Google Scholar 

  26. Leconte I, Van Beers BE, Lacrosse M, et al. (2000) Focal nodular hyperplasia: natural course observed with CT and MRI. J Comput Assist Tomogr 24:61–66

    Article  PubMed  CAS  Google Scholar 

  27. Nguyen BN, Flejou JF, Terris B, et al. (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23:1441–1454

    Article  PubMed  CAS  Google Scholar 

  28. Cherqui D, Rahmouni A, Charlotte F, et al. (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22:1674–1681

    Article  PubMed  CAS  Google Scholar 

  29. Brancatelli G, Federle MP, Grazioli L, et al. (2001) Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 219:61–68

    PubMed  CAS  Google Scholar 

  30. Johnson PT, Zaheer A, Anders R, et al. (2010) Dual-phase computed tomographic angiography of focal nodular hyperplasia: defining predictable postcontrast attenuation levels relative to aorta and inferior vena cava. J Comput Assist Tomogr 34:720–724

    Article  PubMed  Google Scholar 

  31. Welch TJ, Sheedy PF 2nd, Johnson CM, et al. (1985) Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US, and scintigraphy. Radiology 156:593–595

    PubMed  CAS  Google Scholar 

  32. Yang CY, Ho MC, Jeng YM, et al. (2007) Management of hepatic angiomyolipoma. J Gastrointest Surg 11:452–457

    Article  PubMed  Google Scholar 

  33. Nonomura A, Mizukami Y, Kadoya M (1994) Angiomyolipoma of the liver: a collective review. J Gastroenterol 29:95–105

    Article  PubMed  CAS  Google Scholar 

  34. Buell JF, Tranchart H, Cannon R, et al. (2010) Management of benign hepatic tumors. Surg Clin North Am 90:719–735

    Article  PubMed  Google Scholar 

  35. Dalle I, Sciot R, de Vos R, et al. (2000) Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology 36:443–450

    Article  PubMed  CAS  Google Scholar 

  36. Croquet V, Pilette C, Aube C, et al. (2000) Late recurrence of a hepatic angiomyolipoma. Eur J Gastroenterol Hepatol 12:579–582

    Article  PubMed  CAS  Google Scholar 

  37. Mortele KJ, Ros PR (2002) Benign liver neoplasms. Clin Liver Dis 6:119–145

    Article  PubMed  Google Scholar 

  38. Mergo PJ, Ros PR (1998) Benign lesions of the liver. Radiol Clin North Am 36:319–331

    Article  PubMed  CAS  Google Scholar 

  39. Soe KL, Soe M, Gluud C (1992) Liver pathology associated with the use of anabolic–androgenic steroids. Liver 12:73–79

    PubMed  CAS  Google Scholar 

  40. Reddy KR, Kligerman S, Levi J, et al. (2001) Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 67:173–178

    PubMed  CAS  Google Scholar 

  41. Rabe T, Feldmann K, Grunwald K, et al. (1994) Liver tumours in women on oral contraceptives. Lancet 344:1568–1569

    Article  PubMed  CAS  Google Scholar 

  42. Meissner K (1998) Hemorrhage caused by ruptured liver cell adenoma following long-term oral contraceptives: a case report. Hepatogastroenterology 45:224–225

    PubMed  CAS  Google Scholar 

  43. Dokmak S, Paradis V, Vilgrain V, et al. (2009) A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705

    Article  PubMed  Google Scholar 

  44. Guttmacher AE, Marchuk DA, White RI Jr (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918–924

    Article  PubMed  CAS  Google Scholar 

  45. Ianora AA, Memeo M, Sabba C, et al. (2004) Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement. Radiology 230:250–259

    Article  PubMed  Google Scholar 

  46. Garcia-Tsao G, Korzenik JR, Young L, et al. (2000) Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343:931–936

    Article  PubMed  CAS  Google Scholar 

  47. Buscarini E, Buscarini L, Danesino C, et al. (1997) Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol 26:111–118

    Article  PubMed  CAS  Google Scholar 

  48. Memeo M, Stabile Ianora AA, Scardapane A, et al. (2004) Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings. Abdom Imaging 29:211–220

    Article  PubMed  CAS  Google Scholar 

  49. Buscarini E, Buscarini L, Civardi G, et al. (1994) Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings. AJR Am J Roentgenol 163:1105–1110

    Article  PubMed  CAS  Google Scholar 

  50. Hashimoto M, Tate E, Nishii T, et al. (2003) Angiography of hepatic vascular malformations associated with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 26:177–180

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, Johns Hopkins University, Baltimore, MD, USA

    Sameer Ahmed

  2. Department of Radiology, Johns Hopkins Hospital, Baltimore, MD, 21287, USA

    Pamela T. Johnson & Elliot K. Fishman

  3. Department of Radiology, Johns Hopkins Hospital, 601 N Caroline Street, Room 3140 D, Baltimore, MD, 21287, USA

    Pamela T. Johnson

Authors
  1. Sameer Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pamela T. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elliot K. Fishman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pamela T. Johnson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahmed, S., Johnson, P.T. & Fishman, E.K. Defining vascular signatures of benign hepatic masses: role of MDCT with 3D rendering. Abdom Imaging 38, 755–762 (2013). https://doi.org/10.1007/s00261-012-9956-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-012-9956-5

Keywords

Search

Navigation